Abstract 13230: Serum Cystatin C is an Alternative Measure of Renal Function and is Superior to Serum Creatinine for Prediction of Adverse Events in Left Ventricular Assist Device Patients
IntroductionEstimated glomerular filtration rate (eGFR) is reported to improve shortly after left ventricular assist device (LVAD) and is also predictive of adverse events. However, changes in muscle mass (MM) may affect the accuracy of serum creatinine (sCr) based eGFR. Cystatin C (CysC) estimates...
Gespeichert in:
Veröffentlicht in: | Circulation (New York, N.Y.) N.Y.), 2018-11, Vol.138 (Suppl_1 Suppl 1), p.A13230-A13230 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!